Scientific Library
What is the future of mRNA based therapeutics, and their main challenges?
mRNA is a ribonucleic acid used by cells as an intermediate carrier of the genetic information contained in the DNA to synthesize proteins, and corresponds to the copy of one of the two strands of DNA.
How can CRISPR/Cas9 be used to edit genomes?
Genes are key components of our lives. With many other factors, they contribute to shaping us, making people and any other living organism what they are. Genomes, whether human or not, are able to evolve
Elevate Your Proteomic Research with Tebubio’s Biomarker & Biostatistics Expertise
Access an engaging on-demand webinar to discover how our Europe-based Contract Research Service Laboratory Platform, led by a team of expert scientists and biostatisticians, can help you overcome challenges
Biological samples solutions: the chalenges of in vitro models
Access this on-demand webinar to discover how Tebubio leverages its expertise to help you source high-quality human biological samples, enabling you to develop the in-vitro model best suited to your research
Accelerate your mRNA-based proof-of-concepts studies with Tebubio
Watch this on-demand webinar to learn how Tebubio's Contract Research Service laboratory and experts can help you overcome the key challenges in developing innovative mRNA-based therapies.
Enhance Your Therapeutic mRNA Research Projects with Modified NTPs
How Modified NTPs are Revolutionising mRNA Vaccine Technology
In recent years, the spotlight on mRNA (messenger RNA) technology has intensified, largely due to its pivotal role in developing COVID-19 vaccines
Optimising mRNA for Therapeutics: The Synergy of CleanCap Technology and Minimal UTRs
mRNA and UTRs: Unlocking New Frontiers in Therapeutic Innovation
Over the past five years, there has been an explosive surge in scientific interest surrounding messenger RNA (mRNA), as this small but
Revolutionising mRNA Production: When Simplicity Meets Efficiency
mRNA-Based Therapeutics: Pioneering the Future of Medicine
Over the past few years, mRNA-based therapeutics have emerged as a promising approach to treat various diseases, including cancer, infectious
Unlocking the Next Frontier in Immuno-Oncology: Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
In the ever-evolving field of immuno-oncology, the race to develop the most effective cell-based therapies has never been more urgent—or
The Full TriLink Catalog Expertly Delivered by Tebubio
Looking for high-quality mRNA, nucleotides, and custom oligonucleotides?Tebubio delivers the complete TriLink catalogue, giving researchers easy access to industry-leading reagents.
How to Identify Efficient LNP Formulations for Your Model? Insights from Tebubio's Delivery Platform
Access an engaging on-demand webinar to discover how our Europe-based Contract Research Service Laboratory can help you screen the most effective LNP formulations for optimal RNA delivery into your cell
Development and Imaging Validation of Fluorescent Lipid Nanoparticles for RNA Delivery Applicable to Personalized In Vitro Oncology Models
Discover how Tebubio's innovative LNP platform enables real-time tracking of RNA delivery in oncology models. Explore our latest findings and applications for personalized medicine.